Supriya Lifescience Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Supriya Lifescience Limited generated cash of $1,133,070,000, which is more than the previous year. Cash used in financing activities reached the amount of -$223,590,000 last year. Net change in cash is therefore -$826,260,000.
Cash Flow
| 2018 | 174.52M | -47.12M | -97.09M |
|---|---|---|---|
| 2020 | 1.16B | -245.25M | -292.3M |
| 2021 | 799.3M | -474.1M | -149.31M |
| 2023 | 661.87M | -1.33B | -33.68M |
| 2024 | 1.13B | -1.73B | -223.59M |
SUPRIYA.NS Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.57B | 2.27B | 747.05M | 123.98M | -58.74M |
Operating activities | |||||
Net income | 1.19B | 1.23B | 1.67B | 962.27M | 87.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 158.11M | 118.06M | 66.78M | 63.76M | 53.32M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -270.19M | 305.19M | -218.7M | 74.65M | -37.89M |
Inventories | 305.21M | -234.58M | -230.22M | -187.26M | 65.17M |
Accounts payable | -46.59M | 152.56M | 16.53M | 52.64M | 11.38M |
Cash generated by operating activities | 1.13B | 661.87M | 799.3M | 1.16B | 174.52M |
Investing activities | |||||
Purchases Of Investments | 0 | -252.43M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.45B | -1.08B | -482.41M | -245.25M | -49.3M |
Acquisitions Net | 0 | 5.43M | 14.4M | 0 | 2.18M |
Cash generated by investing activities | -1.73B | -1.33B | -474.1M | -245.25M | -47.12M |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -48.29M | -48.29M | -39.56M | -176.46M | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -166.25M | -46.7M | -116.66M | -76.28M | -87.26M |
Cash used in financing activities | -223.59M | -33.68M | -149.31M | -292.3M | -97.09M |
Net Change In Cash | -826.26M | -703.26M | 175.88M | 623.07M | 86.1M |
Cash at end of period | 749.56M | 1.57B | 922.93M | 747.05M | 27.36M |
| Data source | Data source | Data source | Data source | Data source |